ColBar’s Glymatrix™ cross linking technology is the subject of several international patents. It results in a collagen matrix that looks and feels like part of the patient’s own tissue. Being an entirely new development, it is expected to make the use of collagen much more widespread in cosmetic and reconstructive medicine.